Boston Scientific (BSX): Sen. John Boozman disclosed a purchase $1K–$15K
Sen. John Boozman disclosed a purchase of Boston Scientific in the $1K–$15K range.
- $1,001–$15,000
- Reported range · official band, not an exact amount
- 21 days
- Disclosure lag
- Traded
- Feb 13, 2025
- Disclosed
- Mar 6, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Dec 3, 2024InsiderOfficer purchased ~$4.5K of BSX shares in the open market
- Dec 10, 2024InsiderOfficer sold ~$1.8K of BSX shares in the open market
- Jan 2, 2025InsiderOfficer sold ~$371K of BSX shares in the open market
- Jan 3, 2025Insider · 3 peopleInsiders: 3 sales (~$1.7M)
- Feb 3, 2025Insider · 1 personInsiders: 2 sales (~$1.8M)
- Feb 6, 2025FDAFDA device clearance: Resolution Clip (M00522600); Resolution Clip (M00522601); Resolution Clip (M00522602); Resolution Clip (M00522610); Resolution Clip (M00522611); Resolution Cli…
- Feb 7, 2025InsiderOfficer sold ~$685K of BSX shares in the open market
- Feb 11, 2025InsiderDirector sold ~$1.27M of BSX shares in the open market
- Feb 12, 2025Insider · 3 peopleInsiders: 3 sales (~$3.6M)
- Feb 13, 2025 · this disclosureCongressDisclosed purchase of BSX — reported range $1,001 - $15,000
What came next
- Feb 14, 2025InsiderOfficer sold ~$128K of BSX shares in the open market
- Feb 18, 2025Insider · 2 peopleInsiders: 3 sales (~$2.1M)
- Feb 19, 2025Insider · 3 peopleInsiders: 3 sales (~$7.6M)
- Feb 21, 2025InsiderOfficer sold ~$505K of BSX shares in the open market
- Feb 24, 2025Insider · 2 peopleInsiders: 2 sales (~$1.9M)
- Feb 24, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
- Feb 25, 2025InsiderOfficer sold ~$280K of BSX shares in the open market
- Feb 28, 2025InsiderOfficer sold ~$1M of BSX shares in the open market
- Mar 3, 2025InsiderOfficer sold ~$750K of BSX shares in the open market
- Mar 3, 2025CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
- Mar 4, 2025InsiderOfficer sold ~$50K of BSX shares in the open market
- Mar 17, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
- Mar 20, 2025FDAFDA device clearance: iSLEEVE Introducer Set
- Mar 21, 2025FDAFDA device clearance: Navigator HD Ureteral Access Sheath Set 11/13 F x 28cm (M0062502210); Navigator HD Ureteral Access Sheath Set 11/13 F x 36cm (M0062502220); Navigator HD Ure…
- Mar 21, 2025InsiderOfficer sold ~$487K of BSX shares in the open market
- Mar 24, 2025FDARecall: IceSeed 1.5 CX S NEEDLE OUS, Cryoablation Needle, REF H7493967334100. The needles are intended to convert high-pressure gas to either a very cold Freezing appl…
- Mar 24, 2025FDARecall: IceSeed 1.5 CX NEEDLE OUS, Cryoablation Needle, REF H7493967534170. The needles are intended to convert high-pressure gas to either a very cold Freezing applic…
- Mar 24, 2025FDARecall: IceSeed 1.5 CX S NEEDLE US, Cryoablation Needle, REF H7493967233100. The needles are intended to convert high-pressure gas to either a very cold Freezing appli…
- Mar 24, 2025FDARecall: IceSeed 1.5 CX NEEDLE US, Cryoablation Needle, REF H7493967433170. The needles are intended to convert high-pressure gas to either a very cold Freezing applica…
- Apr 1, 2025InsiderCEO sold ~$16.4M of BSX shares in the open market
How to read Senate eFD periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Boston Scientific
For Boston Scientific, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 7 Congress trade reports, 2 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BSX page.
Other recent filings by Sen. John Boozman
- Senate eFD periodic transaction report at Aptiv (APTV)Oct 21, 2026
- Senate eFD periodic transaction report at Micron (MU)Oct 21, 2026
- Senate eFD periodic transaction report at Micron (MU)Oct 21, 2026
- Senate eFD periodic transaction report at Cisco (CSCO)Oct 21, 2026
- Senate eFD periodic transaction report at Realty Income (O)Oct 21, 2026
The full history of Sen. John Boozman is on the profile page.
How this filing works
Explore the data
Common questions
Which member of Congress traded Boston Scientific (BSX) stock, and how much?
Sen. John Boozman disclosed a purchase of Boston Scientific in the $1K–$15K range. Reported range, not an exact amount, Joint account.
When did it happen, and when was it made public?
Traded: Feb 13, 2025. Disclosed: Mar 6, 2025. That is 21 days between the two dates.
Why is the amount a range and not an exact figure?
Members of Congress report each trade in a bracket set by law ($1,001 to $15,000, $15,001 to $50,000, and so on), never an exact amount. OQRO keeps the bracket as filed and does not estimate a figure inside it.
Where does this information come from?
From the Senate eFD periodic transaction report, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Boston Scientific recently?
For Boston Scientific, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 7 Congress trade reports, 2 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days. They are listed on the BSX page.
Does this mean BSX stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Boston Scientific
- SEC Form 13F-HRNov 16, 2026
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
Everything OQRO holds on this company is on its BSX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
